Here is some other vaccine news of note for the week.

Takeda's dengue vaccine induced sustained antibody responses in children, topline phase 2 data showed.

Here is some other vaccine news of note for this week.

China's FDA approved a domestically developed Ebola vaccine based on a different virus type from GSK's and Merck's shots.

Young biotech Codagenix just secured $3 million in funding to advance its live-attenuated RSV vaccine candidate.

A large-scale phase 3 study shows that Merck's Gardasil 9 vaccine protects against HPV-related cancers for at least six years.

Researchers in England are kicking off the world's first large human trial of a "universal" influenza shot.

Serum Institute of India has new results from a phase 3 trial of its rotavirus vaccine as it preps to deliver millions of doses.